Development and characterization of nimodipine solid dispersions of PEG 6000 or Poloxamer 407 / Desenvolvimento e caracterização de dispersões sólidas de nimodipino empregando PEG 6000 ou Poloxamer 407

AUTOR(ES)

Rogério Nepomuceno Kreidel

DATA DE PUBLICAÇÃO

2010

RESUMO

Nimodipine is a calcium blocker, used in prevention and treatment of ischaemic neurological deficits after aneurismal subarachnoid hemorrhage and cognitive deficit. It exhibits a low solubility in water and it is classified as class two in the Biopharmaceutics Classification System (BCS), thereby dissolution is the ratelimiting step in absorption, which impact on bioavailability. Consequently, the objective of this study was to develop and characterize solid dispersions of nimodipine, prepared with PEG 6000 or Poloxamer 407 and to compare them in terms of nimodipine solubility and dissolution. Solid dispersions were obtained by fusion and solvent methods and they were characterized by differential scanning calorimetry (DSC), infra red spectroscopy (FT-IR) and X-ray diffraction, where results confirmed the formation of solid dispersions. Solubility and dissolution characteristics of nimodipine in solid dispersions and physical mixtures were compared. Solid dispersions containing poloxamer 407 showed better efficiency than PEG in increasing solubility and dissolution rate of nimodipine, and it can be explained due to its surfactant activity. The solubility results obtained with solid dispersions prepared with PEG 6000 (DSPEG-10 = 13,2 g.mL-1) were better than physical mixtures with the same composition (MFPEG-10 = 3,21 g.mL-1) which, in turn, showed increased solubility compared with nimodipine (2,19 g.mL-1). Similar results were observed for dissolution efficiency (DSPEG-10 = 69,11% , MFPEG-10 = 15,61% and nimodipine = 11,68%). The best solubility result was obtained by the formulation prepared by the solvent method with poloxamer 407 as carrier (SOLVP407-10 = 75,61 g.mL-1).

ASSUNTO(S)

estabilidade dos medicamentos polietilenoglicol nimodipino poloxamer stability of drugs dispersões sólidas dissolução farmacotécnica poloxamer solubilidade dissolution polyethylene glycol pharmacotechniques solubility solid dispersions nimodipine

Documentos Relacionados

• Obtenção e caracterização de dispersões sólidas de nimesulida
• Desenvolvimento de dispersões sólidas microparticuladas contendo carbamazepina por spray congealing
• Preparation and characterization of cefuroxime axetil solid dispersions using poloxamer 188
• Preparation of piroxicam microparticulated solid dispersions by spray congealing
• Development of prednisone: Polyethylene glycol 6000 fast-release tablets from solid dispersions: Solid-state characterization, dissolution behavior, and formulation parameters